Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3FCL

Complex of UNG2 and a fragment-based designed inhibitor

3FCL の概要
エントリーDOI10.2210/pdb3fcl/pdb
関連するPDBエントリー3FCF 3FCI 3FCK
分子名称Uracil-DNA glycosylase, 3-{[(4-{[(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]amino}butyl)amino]methyl}benzoic acid, THIOCYANATE ION, ... (4 entities in total)
機能のキーワードdna repair, uracil, uracil dna glycosylase, alternative splicing, disease mutation, dna damage, glycosidase, host-virus interaction, hydrolase, mitochondrion, nucleus, phosphoprotein, transit peptide
由来する生物種Homo sapiens (Human)
細胞内の位置Isoform 1: Mitochondrion. Isoform 2: Nucleus: P13051
タンパク質・核酸の鎖数2
化学式量合計52245.69
構造登録者
Bianchet, M.A.,Chung, S.,Parker, J.B.,Amzel, L.M.,Stivers, J.T. (登録日: 2008-11-21, 公開日: 2009-04-28, 最終更新日: 2023-12-27)
主引用文献Chung, S.,Parker, J.B.,Bianchet, M.,Amzel, L.M.,Stivers, J.T.
Impact of linker strain and flexibility in the design of a fragment-based inhibitor
Nat.Chem.Biol., 5:407-413, 2009
Cited by
PubMed Abstract: The linking together of molecular fragments that bind to adjacent sites on an enzyme can lead to high-affinity inhibitors. Ideally, this strategy would use linkers that do not perturb the optimal binding geometries of the fragments and do not have excessive conformational flexibility that would increase the entropic penalty of binding. In reality, these aims are seldom realized owing to limitations in linker chemistry. Here we systematically explore the energetic and structural effects of rigid and flexible linkers on the binding of a fragment-based inhibitor of human uracil DNA glycosylase. Analysis of the free energies of binding in combination with cocrystal structures shows that the flexibility and strain of a given linker can have a substantial impact on binding affinity even when the binding fragments are optimally positioned. Such effects are not apparent from inspection of structures and underscore the importance of linker optimization in fragment-based drug discovery efforts.
PubMed: 19396178
DOI: 10.1038/nchembio.163
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.7 Å)
構造検証レポート
Validation report summary of 3fcl
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon